With this approval, ARCALIS’s Minami-soma facilities and Meiji Seika Pharmatech Co., Ltd., a subsidiary of Meiji Seika Pharma, have been added as manufacturing sites. The technology transfer was ...

GE HealthCare invests $138 million in Cork, Ireland manufacturing facility to address increasing contrast media demand ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq ... today announced that the company will present three posters for its lead therapeutic candidate, efzofitimod, at the ...

topline data from the study expected in the third quarter of 2025 Current epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. based on real-world evidence SAN DIEGO, Jan. 29, ...

Contact: Ashlee Dunston Sr. Director, Investor Relations and Public Affairs [email protected] Source: aTyr Pharma, Inc. The views and opinions expressed herein are the views and opinions of ...

SAN DIEGO, Jan. 29, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR ... today announced that the company will present three posters for its lead therapeutic candidate, efzofitimod, at the ...

Preliminary details of the poster presentations appear below ... timing and results of EFZO-FIT™, and the epidemiology and treatment practices for pulmonary sarcoidosis in the U.S. These ...

Telangana secures massive investments in energy, technology, and infrastructure projects, creating thousands of jobs and boosting economy.

The Food and Drug Administration (FDA) is spearheading efforts to boost the local manufacturing industry by creating pharmaceutical and medical device ecozones, a key initiative championed by ...